XWEGZFZFVPOOMM-FWQWDFHESA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Gtwn2C9jk4V |
|---|---|
| InChI | InChI=1S/C29H53O9PSi2.C6H15N/c1-13-19-35-39(32,33)38-29(8,22-34-26(31)23-17-15-14-16-18-23)25(30)20-24(37-41(11,12)28(5,6)7)21-36-40(9,10)27(2,3)4;1-4-7(5-2)6-3/h13-18,24-25,30H,1,19-22H2,2-12H3,(H,32,33);4-6H2,1-3H3/t24-,25+,29+;/m0./s1 |
| InChIKey | XWEGZFZFVPOOMM-FWQWDFHESA-N |
| Mol Weight | 734.1 g/mol |
| Molecular Formula | C35H68NO9PSi2 |
| Exact Mass | 733.417023 g/mol |
| Parent InChIKey | RFKVGAFOTVTUOY-BOCWGRARSA-N |
| Enantiomer InChIKey | XWEGZFZFVPOOMM-JDVPECNUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3CN |
QUXBDOPNGWBKHN-BGMCIFGSSA-N
ALLYL-(2R,3R,5R)-1-BENZOYLOXY-5,6-BIS-(TERT.-BUTYLDIMETHYLSILOXY)-2-HYDROXY-2-METHYL-3-HEXANYL-TRIETHYLAMMNONIUM-SALT
3,4,6-Tri-O-benzyl-1-O-(3,4-dimethoxybenzylidene)-5-O-tert-butyldimethylsilyl-D-glucitol
METHYL-3-O-BENZOYL-6-O-(TERT.-BUTYLDIPHENYLSILYL)-2-DEOXY-ALPHA-D-RIBO-HEXOPYRANOSIDE
Gluconic acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester, bis(trimethylsilyl) phosphate, D-
1-D-O-2'-FLUOROPHENYL-MYO-INOSITOL-1-PHOSPHATE
D-altro-2-Heptulose, 1,3,4,5,6-pentakis-O-(trimethylsilyl)-, bis(trimethylsilyl) phosphate
Tonkinenin A
1H-Inden-1-ol, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2,3,3a,4,7,7a-hexahydro-, 4-nitrobenzoate, (1.alpha.,3.alpha.,3a.beta.,7a.beta.)-(.+-.)-
1-BETA-BENZYL-2,3,5-TRI-O-(TERT.-BUTYLDIMETHYLSILYL)-1-DEOXY-D-RIBOFURANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Total Synthesis of an Antitumor Antibiotic, Fostriecin (CI-920) | Journal of the American Chemical Society | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.